Vericel - 22 Year Stock Price History | VCEL

Historical daily share price chart and data for Vericel since 1997 adjusted for splits. The latest closing stock price for Vericel as of July 16, 2019 is 19.45.
  • The all-time high Vericel stock price is 1410.08, which is 7149.8% above the current share price.
  • The Vericel 52-week high stock price is 20.29, which is 4.3% above the current share price.
  • The Vericel 52-week low stock price is 10.00, which is 48.6% below the current share price.
  • The average Vericel stock price for the last 52 weeks is 15.92.
Vericel Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 17.7951 17.7300 20.2900 15.0100 19.4500 11.78%
2018 11.8845 5.9000 18.4400 5.7000 17.4000 219.27%
2017 3.5069 2.9000 6.0000 2.5000 5.4500 81.67%
2016 2.6384 2.5300 6.0800 1.7850 3.0000 16.28%
2015 3.0825 3.1500 3.9500 1.7100 2.5800 -15.13%
2014 3.5103 3.3900 6.4900 2.6100 3.0400 -5.88%
2013 11.9065 26.8000 28.2000 3.2100 3.2300 -87.18%
2012 36.9831 36.2000 52.8000 23.0000 25.2000 -30.77%
2011 50.2729 53.6000 65.4000 35.8000 36.4000 -28.91%
2010 36.4176 54.3040 84.0000 26.8000 51.2000 4.07%
2009 63.6713 84.7840 117.5040 41.6000 49.2000 -38.50%
2008 66.5577 85.1200 120.8000 25.6000 80.0000 -3.85%
2007 198.6193 198.4000 252.8000 83.2000 83.2000 -57.72%
2006 236.4725 337.6000 358.4000 177.6000 196.8000 -41.71%
2005 409.5067 219.2000 648.0000 219.2000 337.6000 48.59%
2004 177.3571 220.8000 267.2000 104.0000 227.2000 6.77%
2003 142.7556 75.2000 283.2000 40.0000 212.8000 182.98%
2002 85.7084 158.2400 168.0000 36.8000 75.2000 -52.04%
2001 197.2304 145.0080 384.0000 120.0000 156.8000 12.00%
2000 424.3533 125.0080 1240.0000 115.0080 140.0000 11.99%
1999 270.6114 440.0000 520.0000 70.0000 125.0080 -72.82%
1998 581.0692 760.0000 1020.0000 290.0800 460.0000 -34.29%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.854B $0.091B
Vericel Corporation is focused on developing patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. The company markets two autologous cell therapy products in the United States: Carticel (R) for the treatment of cartilage defects in the knee, and Epicel (R) for the treatment of severe burns. It is also developing MACI (TM) for the treatment of cartilage defects in the knee, and ixmyelocel-T for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy. Vericel Corporation, formerly Aastrom Biosciences, Inc., is based in United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $108.245B 12.24
Gilead Sciences (GILD) United States $85.342B 10.36
Celgene (CELG) United States $64.552B 10.94
Vertex Pharmaceuticals (VRTX) United States $45.118B 54.54
Biogen (BIIB) United States $44.896B 8.52
Illumina (ILMN) United States $44.438B 51.50
CSL (CSLLY) Australia $35.409B 0.00
Regeneron Pharmaceuticals (REGN) United States $32.605B 15.32
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $27.541B 15.59
Incyte (INCY) United States $17.129B 69.46
Exact Sciences (EXAS) United States $14.845B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.750B 0.00
SINO PHARMACEUT (SBMFF) China $14.154B 0.00
Sarepta Therapeutics (SRPT) United States $11.364B 0.00
Genmab (GNMSF) Denmark $11.067B 56.26
Array BioPharma (ARRY) United States $10.346B 0.00
Seattle Genetics (SGEN) United States $10.192B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.283B 49.21
QIAGEN (QGEN) Netherlands $8.908B 29.26
Galapagos (GLPG) Belgium $8.802B 0.00
Bio-Techne Corp (TECH) United States $7.964B 54.34
Alnylam Pharmaceuticals (ALNY) United States $7.909B 0.00
Guardant Health (GH) United States $7.720B 0.00
Bluebird Bio (BLUE) United States $7.368B 0.00
Amarin (AMRN) Ireland $7.189B 0.00
Exelixis (EXEL) United States $6.482B 16.52
BeiGene (BGNE) Cayman Islands $5.652B 0.00
Ascendis Pharma (ASND) Denmark $4.867B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.719B 0.00
Moderna (MRNA) United States $4.652B 0.00
Blueprint Medicines (BPMC) United States $4.628B 0.00
Horizon Pharma Public (HZNP) Ireland $4.408B 11.35
Repligen (RGEN) United States $4.177B 104.05
ACADIA Pharmaceuticals (ACAD) United States $3.787B 0.00
Spark Therapeutics (ONCE) United States $3.752B 0.00
Mirati Therapeutics (MRTX) United States $3.729B 0.00
China Biologic Products (CBPO) China $3.682B 23.39
Alkermes (ALKS) Ireland $3.668B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.401B 0.00
MorphoSys AG (MOR) Germany $3.316B 0.00
Arena Pharmaceuticals (ARNA) United States $3.062B 6.22
Amicus Therapeutics (FOLD) United States $2.899B 0.00
Immunomedics (IMMU) United States $2.772B 0.00
Medicines (MDCO) United States $2.740B 0.00
UniQure (QURE) Netherlands $2.631B 0.00
Reata Pharmaceuticals (RETA) United States $2.613B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.566B 0.00
Halozyme Therapeutics (HALO) United States $2.468B 0.00
MyoKardia (MYOK) United States $2.308B 0.00
Ligand Pharmaceuticals (LGND) United States $2.299B 19.04
Nabriva Therapeutics AG (NBRV) Ireland $2.251B 0.00
Emergent Biosolutions (EBS) United States $2.231B 19.38
NeoGenomics (NEO) United States $2.216B 145.06
Acceleron Pharma (XLRN) United States $2.160B 0.00
Zai Lab (ZLAB) China $2.106B 0.00
Genomic Health (GHDX) United States $2.078B 44.13
Akcea Therapeutics (AKCA) United States $2.072B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.046B 0.00
Denali Therapeutics (DNLI) United States $1.911B 0.00
Myriad Genetics (MYGN) United States $1.907B 18.97
REGENXBIO (RGNX) United States $1.720B 0.00
Insmed (INSM) United States $1.690B 0.00
Cambrex (CBM) United States $1.501B 18.98
Fate Therapeutics (FATE) United States $1.464B 0.00
AnaptysBio (ANAB) United States $1.431B 0.00
RA PHARMCTL INC (RARX) United States $1.421B 0.00
Innoviva (INVA) United States $1.405B 3.89
Sangamo Therapeutics (SGMO) United States $1.349B 0.00
Athenex (ATNX) United States $1.329B 0.00
Alector (ALEC) United States $1.311B 0.00
Coherus BioSciences (CHRS) United States $1.284B 0.00
Editas Medicine (EDIT) United States $1.198B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.185B 0.00
Epizyme (EPZM) United States $1.174B 0.00
Cara Therapeutics (CARA) United States $1.036B 0.00
Codexis (CDXS) United States $1.031B 0.00
Adverum Biotechnologies (ADVM) United States $1.013B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.013B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.979B 0.00
ANI Pharmaceuticals (ANIP) United States $0.976B 17.31
Twist Bioscience (TWST) United States $0.963B 0.00
Principia Biopharma (PRNB) United States $0.955B 0.00
Zymeworks (ZYME) Canada $0.940B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.928B 0.00
WAVE Life Sciences (WVE) Singapore $0.924B 0.00
Retrophin (RTRX) United States $0.873B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.873B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.856B 0.00
Arvinas (ARVN) United States $0.811B 0.00
Intellia Therapeutics (NTLA) United States $0.755B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.712B 33.60
Precision BioSciences (DTIL) United States $0.699B 0.00
Zealand Pharma (ZEAL) Denmark $0.683B 7.99
Zealand Pharma (ZLDPF) Denmark $0.683B 0.00
Clovis Oncology (CLVS) United States $0.678B 0.00
Cytokineticsorporated (CYTK) United States $0.668B 0.00
Cellectis S.A (CLLS) France $0.647B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.640B 0.00
Intra-Cellular Therapies (ITCI) United States $0.640B 0.00
Heska (HSKA) United States $0.617B 63.16
DBV Technologies S.A (DBVT) France $0.604B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.589B 0.00
Anika Therapeutics (ANIK) United States $0.579B 19.79
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.575B 0.00
Stemline Therapeutics (STML) United States $0.568B 0.00
MiMedx (MDXG) United States $0.546B 0.00
Revance Therapeutics (RVNC) United States $0.542B 0.00
CytomX Therapeutics (CTMX) United States $0.537B 0.00
Pharming Group (PHGUF) Netherlands $0.521B 0.00
Mesoblast (MESO) Australia $0.504B 0.00
PHARMA MAR SA (PHMMF) Spain $0.454B 0.00
UROGEN PHARMA (URGN) United States $0.447B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.442B 0.00
Puma Biotechnology (PBYI) United States $0.417B 0.00
Prothena (PRTA) Ireland $0.386B 0.00
Biofrontera AG (BFRA) Germany $0.385B 0.00
PDL BioPharma (PDLI) United States $0.379B 9.06
AC Immune SA (ACIU) Switzerland $0.377B 24.26
Arcus Biosciences (RCUS) United States $0.376B 0.00
Gritstone Oncology (GRTS) United States $0.373B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Bellus Health (BLUSF) Canada $0.366B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.365B 0.00
Scholar Rock Holding (SRRK) United States $0.359B 0.00
Avid Bioservices (CDMO) United States $0.359B 0.00
Merus (MRUS) Netherlands $0.359B 0.00
Starpharma Holdings (SPHRY) Australia $0.356B 0.00
Prometic Life Sciences (PFSCD) Canada $0.348B 0.00
Albireo Pharma (ALBO) United States $0.346B 0.00
Agenus (AGEN) United States $0.344B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.343B 0.00
BioDelivery Sciences (BDSI) United States $0.340B 0.00
Senesco Technologies (ELOX) United States $0.337B 0.00
Acorda Therapeutics (ACOR) United States $0.331B 5.83
Kadmon Holdings (KDMN) United States $0.329B 0.00
Theratechnologies (THERF) Canada $0.328B 0.00
Syros Pharmaceuticals (SYRS) United States $0.324B 0.00
Protagonist Therapeutics (PTGX) United States $0.309B 0.00
Sorrento Therapeutics (SRNE) United States $0.308B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.304B 0.00
Inovio Pharmaceuticals (INO) United States $0.294B 0.00
Cellular Biomedicine (CBMG) United States $0.270B 0.00
Kindred Biosciences (KIN) United States $0.269B 0.00
PHASEBIO PHARMA (PHAS) United States $0.263B 0.00
ChromaDex (CDXC) United States $0.262B 0.00
Sutro Biopharma (STRO) United States $0.261B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.260B 0.00
Dynavax Technologies (DVAX) United States $0.252B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.247B 0.00
Kamada (KMDA) Israel $0.238B 9.22
ADMA Biologics Inc (ADMA) United States $0.233B 0.00
Athersys (ATHX) United States $0.232B 0.00
Geron (GERN) United States $0.226B 0.00
Palatin Technologies (PTN) United States $0.222B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.221B 0.00
Cel-Sci (CVM) United States $0.220B 0.00
Cerecor (CERC) United States $0.210B 0.00
MannKind (MNKD) United States $0.205B 0.00
Five Prime Therapeutics (FPRX) United States $0.204B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.198B 0.00
CorMedix Inc (CRMD) United States $0.198B 0.00
Abeona Therapeutics (ABEO) United States $0.196B 0.00
Synlogic (SYBX) United States $0.195B 0.00
Mersana Therapeutics (MRSN) United States $0.191B 0.00
Affimed (AFMD) Germany $0.191B 0.00
OSMOTICA PHARM (OSMT) United States $0.186B 0.00
Pfenex (PFNX) United States $0.186B 0.00
Spero Therapeutics (SPRO) United States $0.185B 0.00
POXEL SA FRANCE (PXXLF) $0.184B 0.00
Arsanis (XFOR) United States $0.183B 0.00
Compugen (CGEN) Israel $0.182B 0.00
Enzo Biochem (ENZ) United States $0.178B 0.00
BioTime (BTX) United States $0.177B 11.80
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Nicox SA (NICXF) France $0.163B 0.00
XOMA (XOMA) United States $0.158B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.157B 0.00
Strongbridge Biopharma (SBBP) United States $0.150B 8.63
OvaScience (MLND) United States $0.148B 0.00
Cue Biopharma (CUE) United States $0.148B 0.00
TOCAGEN INC (TOCA) United States $0.142B 0.00
Liquidia Technologies (LQDA) United States $0.140B 0.00
Adocia (ADOCY) France $0.140B 0.00
Celyad SA (CYAD) Belgium $0.140B 0.00
Northwest Biotherapeutics (NWBO) United States $0.135B 0.00
Dyadic (DYAI) United States $0.134B 0.00
NantKwest (NK) United States $0.127B 0.00
Seres Therapeutics (MCRB) United States $0.125B 0.00
Aptinyx (APTX) United States $0.123B 0.00
Alcobra (ARCT) United States $0.120B 0.00
Arbutus Biopharma (ABUS) Canada $0.119B 0.00
Aduro Biotech (ADRO) United States $0.119B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.119B 0.00
Menlo Therapeutics (MNLO) United States $0.118B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.117B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.116B 0.00
Verastem (VSTM) United States $0.114B 0.00
Novavax (NVAX) United States $0.109B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.103B 0.00
Catalyst Biosciences (CBIO) United States $0.103B 0.00
Checkpoint Therapeutics (CKPT) United States $0.103B 0.00
SESEN BIO, INC (SESN) United States $0.100B 0.00
Trevena (TRVN) United States $0.097B 0.00
Curis (CRIS) United States $0.094B 0.00
Fortress Biotech (FBIO) United States $0.093B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.085B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.084B 0.00
Pluristem Therapeutics (PSTI) Israel $0.084B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.083B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.083B 0.00
VBI Vaccines (VBIV) United States $0.082B 0.00
AquaBounty Technologies (AQB) United States $0.081B 0.00
Unum Therapeutics (UMRX) United States $0.079B 0.00
VTv Therapeutics (VTVT) United States $0.078B 0.00
Selecta Biosciences (SELB) United States $0.075B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.073B 0.00
Idera Pharmaceuticals (IDRA) United States $0.073B 0.00
Signal Genetics (MGEN) United States $0.072B 0.00
Orgenesis (ORGS) United States $0.072B 0.00
Applied Genetic Technologies (AGTC) United States $0.069B 37.90
Organovo Holdings (ONVO) United States $0.067B 0.00
ARAVIVE, INC (ARAV) United States $0.063B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.062B 0.00
Alimera Sciences (ALIM) United States $0.062B 0.00
Protalix BioTherapeutics (PLX) Israel $0.060B 0.00
Antibe Therapeutics (ATBPF) Canada $0.060B 0.00
Prima BioMed (IMMP) Australia $0.059B 0.00
Invo BioScience (IVOB) United States $0.057B 0.00
NewLink Genetics (NLNK) United States $0.054B 0.00
Oncobiologics (OTLK) United States $0.053B 0.00
Ophthotech (ISEE) United States $0.051B 0.00
Proteostasis Therapeutics (PTI) United States $0.050B 0.00